Largest biotech companies in the United States by market cap
Adaptive Biotechnologies has the lowest figure of the 20 biotech companies in the United States ranked by market value, at DKK 31.7B, followed by Scholar Rock Holding (DKK 41.9B) and Kodiak Sciences (DKK 43.8B). Figures as of 19 Nov 2026, 18:05 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 20
- Lowest
- Adaptive BiotechnologiesDKK 31.7B
- Median
- DKK 71B
- Combined market value
- DKK 5.03T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Biotech▾
| # | Company | Market cap ↑ | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|
| 1 | Adaptive BiotechnologiesADPT · Health Care | DKK 31.7B | DKK 195.53 | 0.91% up | 74% up | ||
| 2 | Scholar Rock HoldingSRRK · Health Care | DKK 41.9B | DKK 343.34 | 5.06% up | 26% up | ||
| 3 | Kodiak SciencesKOD · Health Care | DKK 43.8B | DKK 670.14 | 0.63% up | 399% up | ||
| 4 | ImmunovantIMVT · Health Care | DKK 46.1B | DKK 222.90 | 1.30% down | 46% up | ||
| 5 | ImmunityBioIBRX · Health Care | DKK 47.8B | DKK 44.92 | 1.51% down | 232% up | ||
| 6 | CG OncologyCGON · Health Care | DKK 49.8B | DKK 558.11 | 2.47% up | 97% up | ||
| 7 | Twist BioscienceTWST · Health Care | DKK 54.5B | DKK 799.97 | 0.99% up | 346% up | ||
| 8 | VaxcytePCVX · Health Care | DKK 63.9B | DKK 403.59 | 1.30% up | 23% up | ||
| 9 | Krystal BiotechKRYS · Health Care | DKK 64B | DKK 2,159.99 | 0.61% up | 54% up | ||
| 10 | Kymera TherapeuticsKYMR · Health Care | DKK 70.3B | DKK 823.93 | 0.09% down | 87% up | ||
| 11 | Halozyme TherapeuticsHALO · Health Care | DKK 71.7B | DKK 629.22 | 3.53% down | 39% up | ||
| 12 | RepligenRGEN · Health Care | DKK 74.6B | DKK 1,166.76 | 0.75% down | 12% up | ||
| 13 | Bio-TechneTECH · Health Care | DKK 77.8B | DKK 495.03 | 0.05% down | 24% up | ||
| 14 | Neurocrine BiosciencesNBIX · Health Care | DKK 108.5B | DKK 1,072.37 | 3.29% down | 17% up | ||
| 15 | ExelixisEXEL · Health Care | DKK 109.7B | DKK 449.75 | 3.27% down | 63% up | ||
| 16 | Revolution MedicinesRVMD · Health Care | DKK 237.9B | DKK 1,100.01 | 1.09% up | 129% up | ||
| 17 | BiogenBIIB · Health Care | DKK 248.3B | DKK 1,679.66 | 1.87% down | 49% up | ||
| 18 | ModernaMRNA · Health Care | DKK 556.1B | DKK 1,374.35 | 2.58% up | 780% up | ||
| 19 | Gilead SciencesGILD · Health Care | DKK 1.41T | DKK 1,139.77 | 0.93% down | 35% up | ||
| 20 | AmgenAMGN · Health Care | DKK 1.62T | DKK 2,996.99 | 0.83% down | 32% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8083 DKK).
Questions and answers
Which biotech companies in the United States have the lowest market cap?
Adaptive Biotechnologies (DKK 31.7B), Scholar Rock Holding (DKK 41.9B) and Kodiak Sciences (DKK 43.8B) have the lowest market cap of the 20 biotech companies in the United States ranked here as of 19 Nov 2026, 18:05 UTC.
How many biotech companies in the United States are in this ranking?
20 are ranked by market value.
What are these biotech companies in the United States worth together?
The 20 biotech companies in the United States ranked by market value have a combined market value of DKK 5.03T as of 19 Nov 2026, 18:05 UTC.
What does ranking by market value measure?
What the stock market values the whole company at: its share price times the number of its shares.
Learn how this ranking works
All markets guides →- What market capitalization is, and what it is not
Market capitalization is the share price multiplied by the number of shares outstanding: 1 billion shares at $50 is a $50 billion company. It measures the size the stock market puts on a company's equity today. It is not a sale price, it ignores debt and cash, and index providers often count only the freely traded part, the float.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest biotech companies in the United States by market cap”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states
Underlying data: Yahoo Finance; SEC EDGAR.